(NASDAQ:BYND), EL SEGUNDO, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) — As previously announced, Beyond Meat, Inc. (NASDAQ: BYND) (“Beyond Meat” or “the Company”), a leader in plant-based meat, will host its conference call to discuss its financial results for the third quarter ended September 27, 2025 on Tuesday, November 11, 2025 at 5:00 p.m. Eastern, […]
(NYSE:INSP), NEW YORK, Nov. 07, 2025 (GLOBE NEWSWIRE) — The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE:INSP) securities during the period of August 6, 2024 through August 4, 2025, inclusive (“the Class
(NYSE:TEVA),(TASE:TEVA.TA),(TASE:TEVA), In a new cohort of 27 adults from the IMPACT-TD Registry, up to 77% of participants reported improvements in aspects of their lives impacted by tardive dyskinesia (TD) while taking AUSTEDO or AUSTEDO XR Most (85%) participants taking AUSTEDO or AUSTEDO XR in conjunction with their mental health medications reported that their mental health
AUSTEDO(R) (deutetrabenazine) tablets and AUSTEDO XR(R) (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living GlobeNewswire November 07, 2025 In a new cohort of 27 adults from the IMPACT-TD Registry, up to 77% of participants reported improvements in aspects of their lives impacted by tardive
Beyond Meat(R) to Report Third Quarter 2025 Financial Results on November 10, 2025 and Hold Conference Call on November 11, 2025 GlobeNewswire November 07, 2025 EL SEGUNDO, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) — As previously announced, Beyond Meat, Inc. (NASDAQ: BYND) (“Beyond Meat” or “the Company”), a leader in plant-based meat, will host its
INSP ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Inspire Medical Systems, Inc. Investors GlobeNewswire November 07, 2025 NEW YORK, Nov. 07, 2025 (GLOBE NEWSWIRE) — The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired
NEW YORK CITY, NY / ACCESS Newswire / November 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Avantor, Inc. ("Avantor" or the "Company") (NYSE:AVTR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
https://mma.prnewswire.com/media/1321386/Robbins_LLP_Logo.jpg Company: Avantor, Inc. (NYSE: AVTR) provides scientific products and services for customers in biotechnology, pharmaceuticals, healthcare, education, government, and other industries. Class Period: March 5, 2024 – October 28, 2025 The Case: Robbins LLPreminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Avantor common stock
NEW YORK, NY / ACCESS Newswire / November 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Alkami Technology, Inc. ("Alkami" or the "Company") (NASDAQ:ALKT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Alkami and certain of its officers and/or directors
(CNSX:AIDR),(OTC US:AIRDF),(Other OTC:AIRDF),(Boerse Frankfurt – Freiverkehr:939),(CNSX:AIDR.CN),(Boerse Frankfurt – Freiverkehr:939.F), Vancouver, BC, Nov. 07, 2025 (GLOBE NEWSWIRE) — Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that it has granted an aggregate 831,356 restricted share units (“RSUs“) and 20,964 stock options (“Options“) to consultants and employees of the Company and